Science Explorer Back to mapMap
Discussion
Company · Halifax · Canada

Appili Therapeutics (Canada)

appilitherapeutics.comROR OpenAlex
Research works
2
▲ 157% vs 2018-21
Citations
25
16.7 per fractional work
Top-10% rate
7.4%
all institutions 10.0%
Open access
100%
world 40%
International
59%
world 18%
Appili Therapeutics (Canada)

Not ranked overall: Appili Therapeutics (Canada) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Appili Therapeutics (Canada) work in?

In all years, 62% of research at Appili Therapeutics (Canada) is in Life Sciences, 31% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (38%), Medicine (31%), Immunology and Microbiology (19%).

Life Sciences: 1 fractional works · 62.5% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 37.5% of its workImmunology and Microbiology: 0 fractional works · 18.8% of its workNeuroscience: 0 fractional works · 6.2% of its workHealth Sciences: 0 fractional works · 31.2% of its workMedicine: 0 fractional works · 31.2% of its workPhysical Sciences: 0 fractional works · 6.2% of its workEngineering: 0 fractional works · 6.2% of its workALL ITS WORKAppiliTherapeutics…2fractional works, all years
Life Sciences62%Physical Sciences6%Health Sciences31%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 5 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology137.5%
    2. Immunology and Microbiology018.8%
    3. Neuroscience06.2%
    1. Medicine031.2%
    1. Engineering06.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from Appili Therapeutics (Canada)?

The most cited paper from Appili Therapeutics (Canada) is "Optimized knock-in of point mutations in zebrafish using CRISPR/Cas9" (Sergey V. Prykhozhij, Charlotte J. Fuller, Shelby L. Steele et al., 2018), with 70 citations. Next come "The identification of dual protective agents against cisplatin-induced oto- and nephrotoxicity using the zebrafish model" (24) and "Pharmacodynamics of ATI-2307 in a rabbit model of cryptococcal meningoencephalitis" (6).

Most cited papers
#PaperReleasedCitations
1 Optimized knock-in of point mutations in zebrafish using CRISPR/Cas9 Sergey V. Prykhozhij, Charlotte J. Fuller, Shelby L. Steele et al. · Nucleic Acids Research Open access 24 Jul 2018 70
2 The identification of dual protective agents against cisplatin-induced oto- and nephrotoxicity using the zebrafish model Jaime N. Wertman, Nicole Melong, Matthew R. Stoyek et al. · eLife Open access 28 Jul 2020 24
3 Pharmacodynamics of ATI-2307 in a rabbit model of cryptococcal meningoencephalitis Charles D. Giamberardino, Jennifer L. Tenor, Dena L. Toffaletti et al. · Antimicrobial Agents and Chemotherapy Open access 20 Sep 2023 6
4 Analyses of human immune responses to Francisella tularensis identify correlates of protection Helena Lindgren, Kjell Eneslätt, Igor R. Golovliov et al. · Frontiers in Immunology Open access 15 Sep 2023 6
5 The immune response to Francisella tularensis Derek A Barthels, Robert V. House, H. Carl Gelhaus · Frontiers in Microbiology Open access 25 Apr 2025 5
All 6 most cited papers, with filters and sorting

Which research topics does Appili Therapeutics (Canada) publish most on?

By volume in 2022-now: Poxvirus research and outbreaks, Bacillus and Francisella bacterial research, SARS-CoV-2 and COVID-19 Research and Fungal Infections and Studies.

Poxvirus research and ou…0Poxvirus research and outbreaks: 0 fractional worksBacillus and Francisella…0Bacillus and Francisella bacterial research: 0 fractional worksSARS-CoV-2 and COVID-19 …0SARS-CoV-2 and COVID-19 Research: 0 fractional worksFungal Infections and St…0Fungal Infections and Studies: 0 fractional worksAntifungal resistance and susceptibility: 0 fractional worksPneumocystis jirovecii pneumonia detection and treatment: 0 fractional worksYersinia bacterium, plag…0Yersinia bacterium, plague, ectoparasites research: 0 fractional works
VirologyMolecular BiologyInfectious DiseasesEpidemiology1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Poxvirus research and outbreaks Virology 0 works
  2. 2 Bacillus and Francisella bacterial research Molecular Biology 0 works
  3. 3 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  4. 4 Fungal Infections and Studies Epidemiology 0 works
  5. 5 Antifungal resistance and susceptibility Infectious Diseases 0 works
  6. 6 Pneumocystis jirovecii pneumonia detection and treatment Epidemiology 0 works
  7. 7 Yersinia bacterium, plague, ectoparasites research Genetics 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available100.0%

World: 40% of research is openly available.

with international co-authors59.1%domestic only40.9%

World: 18% is written across borders.

How has Appili Therapeutics (Canada)'s research output changed?

Output in 2022-2025 was 157% higher than in 2018-2021.

still counting20202025

Other research institutions in Halifax

All research institutions in Halifax

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Appili Therapeutics (Canada). Posts are plain text and can be reported.